Eagle Pharmaceuticals, Inc.
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 --
業務概覽 Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advance stages of development and is under review for approval by the Food and Drug Administration.
公司地址 50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ, USA, 07677
電話號碼 +1 201 326-5300
傳真號碼 --
公司網頁 http://www.eagleus.com
員工數量 134
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Steven B. Ratoff Interim Chief Financial Officer, Principal Accounting Officer and Independent Director -- 08/03/2024
Mr. Michael Graves Interim Executive Chairman of the Board and Interim Principal Executive Officer -- 29/11/2023
 
董事會成員
董事會 職務 更新日期
Mr. Steven B. Ratoff Interim Chief Financial Officer, Principal Accounting Officer and Independent Director 08/03/2024
Dr. Jennifer K Simpson, PhD Independent Director 01/05/2023
Dr. Luciana Borio, M.D. Independent Director 01/05/2023
Mr. Robert L. Glenning Independent Director 01/05/2023
Mr. Michael Graves Interim Executive Chairman of the Board and Interim Principal Executive Officer 29/11/2023
Mr. Richard A. Edlin Independent Director 01/05/2023
 
所屬ETF (更新日期: 07/03/2026 03:24)
代號 名稱 佔比% ▼ 持有日期
SLYSPDR® S&P 600 Small Cap ETF0.15%31/05/2023
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0004%31/05/2023
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
EWSCInvesco S&P SmallCap 600® Equal Wt ETF<0.000001%20/03/2023
ITOTiShares Core S&P Total US Stock Mkt ETF<0.000001%27/02/2026
IWCiShares Micro-Cap ETF<0.000001%28/02/2026
IWViShares Russell 3000 ETF<0.000001%28/02/2026
SMLFiShares U.S. Small-Cap Eq Fac ETF<0.000001%27/02/2026
SMMDiShares Russell 2500 ETF<0.000001%27/02/2026
SQLVRoyce Quant Small-Cap Quality Value ETF<0.000001%27/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.